These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 30471427
1. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice. Tonello R, Lee SH, Berta T. J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427 [Abstract] [Full Text] [Related]
3. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy. Singhmar P, Huo X, Li Y, Dougherty PM, Mei F, Cheng X, Heijnen CJ, Kavelaars A. Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966 [Abstract] [Full Text] [Related]
4. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain. Krukowski K, Eijkelkamp N, Laumet G, Hack CE, Li Y, Dougherty PM, Heijnen CJ, Kavelaars A. J Neurosci; 2016 Oct 26; 36(43):11074-11083. PubMed ID: 27798187 [Abstract] [Full Text] [Related]
5. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ. Krukowski K, Nijboer CH, Huo X, Kavelaars A, Heijnen CJ. Pain; 2015 Nov 26; 156(11):2184-2192. PubMed ID: 26473292 [Abstract] [Full Text] [Related]
6. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy. Zhang H, Li Y, de Carvalho-Barbosa M, Kavelaars A, Heijnen CJ, Albrecht PJ, Dougherty PM. J Pain; 2016 Jul 26; 17(7):775-86. PubMed ID: 26979998 [Abstract] [Full Text] [Related]
7. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR. Brain Behav Immun; 2007 Jul 26; 21(5):686-98. PubMed ID: 17174526 [Abstract] [Full Text] [Related]
12. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy. Chine VB, Au NPB, Kumar G, Ma CHE. Mol Neurobiol; 2019 May 26; 56(5):3244-3259. PubMed ID: 30117103 [Abstract] [Full Text] [Related]
13. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. Zhang H, Boyette-Davis JA, Kosturakis AK, Li Y, Yoon SY, Walters ET, Dougherty PM. J Pain; 2013 Oct 26; 14(10):1031-44. PubMed ID: 23726937 [Abstract] [Full Text] [Related]
14. Mu-Opioid Receptor (MOR) Dependence of Pain in Chemotherapy-Induced Peripheral Neuropathy. Araldi D, Staurengo-Ferrari L, Bogen O, Bonet IJM, Green PG, Levine JD. J Neurosci; 2024 Oct 16; 44(42):. PubMed ID: 39256047 [Abstract] [Full Text] [Related]
15. Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers. Ma J, Trinh RT, Mahant ID, Peng B, Matthias P, Heijnen CJ, Kavelaars A. Pain; 2019 Dec 16; 160(12):2877-2890. PubMed ID: 31356453 [Abstract] [Full Text] [Related]
17. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. Koyanagi M, Imai S, Iwamitsu Y, Matsumoto M, Saigo M, Moriya A, Ogihara T, Nakazato Y, Yonezawa A, Nakagawa S, Nakagawa T, Matsubara K. Neuropharmacology; 2021 May 01; 188():108514. PubMed ID: 33684416 [Abstract] [Full Text] [Related]
19. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk. Sekiguchi F, Domoto R, Nakashima K, Yamasoba D, Yamanishi H, Tsubota M, Wake H, Nishibori M, Kawabata A. Neuropharmacology; 2018 Oct 01; 141():201-213. PubMed ID: 30179591 [Abstract] [Full Text] [Related]